Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases

[1]  N. Bander,et al.  Prostate‐specific membrane antigen expression in tumor‐associated vasculature of breast cancers , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[2]  S. Toms,et al.  Molecular Biology of Brain Metastasis , 2014, International journal of molecular sciences.

[3]  N. Keating,et al.  Expected years of life lost for six potentially preventable cancers in the United States. , 2013, Preventive medicine.

[4]  Helle K. Iversen,et al.  Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy , 2012, Radiology and oncology.

[5]  J. Bourgeois,et al.  Cell‐penetrating anti‐GFAP VHH and corresponding fluorescent fusion protein VHH‐GFP spontaneously cross the blood‐brain barrier and specifically recognize astrocytes: application to brain imaging , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  K. Claffey,et al.  Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization , 2012, PloS one.

[7]  Darren Hargrave,et al.  Paediatric and adult malignant glioma: close relatives or distant cousins? , 2012, Nature Reviews Clinical Oncology.

[8]  D. Schiff,et al.  Angiogenic inhibition in high-grade gliomas: past, present and future , 2012, Expert review of neurotherapeutics.

[9]  Xuan Zhang,et al.  New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells. , 2012, International journal of oncology.

[10]  R. Shao,et al.  Glioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation* , 2012, The Journal of Biological Chemistry.

[11]  Robert Langer,et al.  Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.

[12]  Alexander R A Anderson,et al.  Quantifying the Role of Angiogenesis in Malignant Progression of Gliomas: in Silico Modeling Integrates Imaging and Histology Nih Public Access Author Manuscript Introduction , 2011 .

[13]  P. Gutin,et al.  Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme. , 2011, Archives of pathology & laboratory medicine.

[14]  Kornelia Polyak,et al.  Heterogeneity in breast cancer. , 2011, The Journal of clinical investigation.

[15]  S. Pastorino,et al.  Transdifferentiation of glioblastoma cells into vascular endothelial cells , 2011, Proceedings of the National Academy of Sciences.

[16]  L. Ricci-Vitiani,et al.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.

[17]  Rong Wang,et al.  Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.

[18]  P. Steeg,et al.  Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer , 2010, Clinical Cancer Research.

[19]  Y. Nakasu,et al.  [Multidisciplinary management of brain metastases]. , 2010, Gan to kagaku ryoho. Cancer & chemotherapy.

[20]  Ximing J. Yang,et al.  Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. , 2009, Human pathology.

[21]  P. Brastianos,et al.  VEGF inhibitors in brain tumors. , 2009, Clinical advances in hematology & oncology : H&O.

[22]  Ho-Yyoung Lee,et al.  Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors , 2009, The FEBS journal.

[23]  N. Sibson,et al.  The Vascular Basement Membrane as “Soil” in Brain Metastasis , 2009, PloS one.

[24]  P. Low,et al.  Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. , 2009, Molecular pharmaceutics.

[25]  Masahiro Inoue,et al.  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. , 2009, Cancer cell.

[26]  Eun Seong Lee,et al.  Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. , 2008, Small.

[27]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[28]  A. Ieva,et al.  Antiangiogenic Strategies in Medulloblastoma: Reality or Mystery , 2008, Pediatric Research.

[29]  P. Pandolfi,et al.  PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. , 2008, Genes & development.

[30]  L. Chin,et al.  Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.

[31]  A. Gregory Sorensen,et al.  Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.

[32]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[33]  L. Crinò,et al.  Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors. , 2007, The oncologist.

[34]  N. Patil,et al.  Brain metastases from breast cancer: management approach. , 2007, Journal of cancer research and therapeutics.

[35]  G. Sauter,et al.  Prostate‐specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique , 2007, Histopathology.

[36]  A. Vicha,et al.  Expression of glutamate carboxypeptidase II in human brain , 2007, Neuroscience.

[37]  S. Vallabhajosula,et al.  Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[39]  Philippe Lambin,et al.  A pathology-based substrate for target definition in radiosurgery of brain metastases. , 2006, International journal of radiation oncology, biology, physics.

[40]  Dianqing Wu,et al.  Prostate-Specific Membrane Antigen Regulates Angiogenesis by Modulating Integrin Signal Transduction , 2006, Molecular and Cellular Biology.

[41]  R. Kole,et al.  Analysis of prostate-specific membrane antigen splice variants in LNCap cells. , 2006, Oligonucleotides.

[42]  J. Posner,et al.  Brain metastases: epidemiology and pathophysiology , 2005, Journal of Neuro-Oncology.

[43]  Pieter Wesseling,et al.  Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option , 2004, Clinical Cancer Research.

[44]  R. Santucci,et al.  Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. , 2002, Cancer research.

[45]  A. Ruifrok,et al.  Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.

[46]  V. Reuter,et al.  Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. , 1999, Cancer research.

[47]  J. Nakayama,et al.  Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization. , 1997, Cancer research.

[48]  C. Cordon-Cardo,et al.  Prostate-specific membrane antigen expression in normal and malignant human tissues. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  P. Schellhammer,et al.  Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. , 1995, Urologic oncology.

[50]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.